Daratumumab in Treatment of PGNMID and C3 GN
Clinical trial NCT03095118 · COMPLETED
Trial details
- NCT number
- NCT03095118
- Sponsor
- Fernando Fervenza
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-07
- Primary completion
- 2019-10-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.